Ibaraki, Japan

Yoshiko Yokota



Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1987-2001

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Yoshiko Yokota

Introduction

Yoshiko Yokota is a notable inventor based in Ibaraki, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of infections and diseases. With a total of 6 patents to her name, her work has had a considerable impact on medical science.

Latest Patents

One of her latest patents involves the use of bicozamycin for the manufacture of a medicament aimed at treating infections caused by enterohemorrhagic E. coli. This invention focuses on the prophylaxis and treatment of infections with verotoxin-producing strains, as well as eradicating these strains in livestock. Another significant patent is a composition for the prevention and treatment of AIDS. This method addresses lymphadenopathy, AIDS, and AIDS-related complex by administering FK-565 or its pharmaceutically acceptable salt along with AZT.

Career Highlights

Yoshiko Yokota has worked with prominent companies in the pharmaceutical industry, including Fujisawa Pharmaceutical Company, Ltd. and Aktiebolaget Hassle. Her experience in these organizations has allowed her to develop innovative solutions that address critical health issues.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues such as Yasuhiro Mine and Yoshimi Wakai. These partnerships have fostered a creative environment that has led to groundbreaking advancements in her field.

Conclusion

Yoshiko Yokota's contributions to medical science through her patents and collaborations highlight her role as a significant inventor in the pharmaceutical industry. Her work continues to influence the treatment of serious health conditions, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…